Toray Industries, Inc. - Product Pipeline Review - 2016

  • ID: 3961133
  • Company Profile
  • 43 pages
  • Global Markets Direct
  • Toray Industries Inc.
1 of 4
Toray Industries, Inc. - Product Pipeline Review - 2016

‘Toray Industries, Inc. - Product Pipeline Review - 2016’, provides an overview of the Toray Industries, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Toray Industries, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Toray Industries, Inc.
- The report provides overview of Toray Industries, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Toray Industries, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Toray Industries, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Toray Industries, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Toray Industries, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Toray Industries, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Toray Industries, Inc. Snapshot

Toray Industries, Inc. Overview

Key Facts

Toray Industries, Inc. - Research and Development Overview

Key Therapeutic Areas

Toray Industries, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Toray Industries, Inc. - Pipeline Products Glance

Toray Industries, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Toray Industries, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Toray Industries, Inc. - Drug Profiles

beraprost sodium ER - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

GT-0198 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HIS-388 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Agonize Prostacyclin Receptor for Bleeding and Clotting Disorders - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Antagonize Alpha1B Adrenoceptor - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Antagonize CCR3 for Undisclosed Indication - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Block TRPV1 for Overactive Bladder - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Antagonize mGluR5 for Anxiety - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit Dipeptidyl Peptidase IV for Type 2 Diabetes - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit Soluble Epoxide Hydrolase for Pulmonary Arterial Hypertension - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

TRK-390 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

TRK-700 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Toray Industries, Inc. - Pipeline Analysis

Toray Industries, Inc. - Pipeline Products by Target

Toray Industries, Inc. - Pipeline Products by Route of Administration

Toray Industries, Inc. - Pipeline Products by Molecule Type

Toray Industries, Inc. - Pipeline Products by Mechanism of Action

Toray Industries, Inc. - Dormant Projects

Toray Industries, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

beraprost sodium SR

TAK-363

Toray Industries, Inc. - Company Statement

Toray Industries, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Toray Industries, Inc., Key Facts

Toray Industries, Inc. - Pipeline by Indication, 2016

Toray Industries, Inc. - Pipeline by Stage of Development, 2016

Toray Industries, Inc. - Monotherapy Products in Pipeline, 2016

Toray Industries, Inc. - Partnered Products in Pipeline, 2016

Toray Industries, Inc. - Partnered Products/ Combination Treatment Modalities, 2016

Toray Industries, Inc. - Out-Licensed Products in Pipeline, 2016

Toray Industries, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016

Toray Industries, Inc. - Phase II, 2016

Toray Industries, Inc. - Preclinical, 2016

Toray Industries, Inc. - Discovery, 2016

Toray Industries, Inc. - Pipeline by Target, 2016

Toray Industries, Inc. - Pipeline by Route of Administration, 2016

Toray Industries, Inc. - Pipeline by Molecule Type, 2016

Toray Industries, Inc. - Pipeline Products by Mechanism of Action, 2016

Toray Industries, Inc. - Dormant Developmental Projects,2016

Toray Industries, Inc. - Discontinued Pipeline Products, 2016

Toray Industries, Inc., Other Locations

Toray Industries, Inc., Subsidiaries

List of Figures

Toray Industries, Inc. - Pipeline by Top 10 Indication, 2016

Toray Industries, Inc. - Pipeline by Stage of Development, 2016

Toray Industries, Inc. - Monotherapy Products in Pipeline, 2016

Toray Industries, Inc. - Pipeline by Top 10 Target, 2016

Toray Industries, Inc. - Pipeline by Route of Administration, 2016

Toray Industries, Inc. - Pipeline by Molecule Type, 2016

Toray Industries, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll